− | '''[[Vaccines|Vaccination]] '''is available and commonly used in the UK. Both vaccines available in the UK are given intranasally and neither protects against re-infection when given during clinical outbreak, but can lessen the severity of the disease. There are also '''inactivated''' vaccines: intranasal/intramuscular administration, which have a gE deletion making this a '''marker vaccine'''. There is an ELISA for gE deletion, which can enable culling of carrier animals. | + | '''[[Vaccines|Vaccination]] '''is available and commonly used in the UK. Both vaccines available in the UK are given intranasally and neither protects against re-infection when given during clinical outbreak, but can lessen the severity of the disease. There are also '''inactivated''' vaccines: intranasal/intramuscular administration, which have a gE deletion making this a '''marker vaccine'''. There is an ELISA for gE deletion, which can enable culling of carrier animals. |